Comparison of Short-term Outcomes of Robotic and Laparoscopic Surgery in Patients With Different Body Mass Index for Mid and Low Rectal Cancer
- Disease/Condition
- Rectal Cancer
- Drug/Device/Intervention
- robotic surgery
- Study type
- Observational
- Intervention type
- procedure
- Primary sponsor
- Daorong Wang
- Funder
- Northern Jiangsu People's Hospital
- Location
- Yangzhou, China
- Phase
- N/A
- Start date
- Jan 01, 2019
- End date
- Apr 29, 2024
- Enrollment
- 1413 participants
Oncological outcomes,the frequency of complications
Numerous comparison studies on the outcomes of robotic and laparoscopic surgery in the
 treatment of rectal cancer have been undertaken and reported. But there aren't many studies
 that compare the safety and effectiveness of the two surgery procedures used to treat people
 with mid and low rectal cancer who have different body mass indexes (BMIs). This study was
 done to organize the clinical data we had at our hospital so we could compare the
 perioperative effectiveness of two minimally invasive approaches for people with different
 BMIs.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06396975
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06396975 through Pure Global AI's free database. This phase not specified trial is sponsored by Daorong Wang and is currently Completed. The study focuses on Rectal Cancer. Target enrollment is 1413 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.